 |
|
Localized, Operable Soft Tissue Sarcoma of the Lower Extremity
Charles Collin, MD;
Steven I. Hadju, MD;
James Godbold, PhD;
Man H. Shiu, MD;
Basil I. Hilaris, MD;
Murray F. Brennan, MD
Arch Surg. 1986;121(12):1425-1433.
Abstract
| |
• Recent developments in adjuvant treatment of soft tissue sarcomas of the extremities have altered the surgical approach to this disease. To assess the effects of changing management on local recurrence rates and to examine factors governing local failure, we reviewed the records of 315 adults with operable, nonmetastatic soft tissue sarcoma of the lower extremity who were treated at one institution over a ten-year period. The median follow-up was 8.2 years. One third of our patients presented with locally recurrent tumors after initial treatment elsewhere. Sixty-six percent of the lesions were above the knee, and 60% were high grade. Two thirds of the patients underwent limb-sparing surgery (LSS), which in the latter half of the study period outnumbered amputations by four to one. Local recurrence was directly related to the adequacy of the surgical margins. Adjuvant radiotherapy and chemotherapy did not significantly decrease local recurrence in patients who underwent LSS, although favorable trends were observed. A significantly increased risk of local failure was associated with age greater than 53 years, presentation with local recurrence, high tumor grade, deep location, positive nodes, and less than adequate surgical margins. Local failure also varied significantly with histologic type and was highest in patients with embryonal rhabdomyosarcoma and neurofibrosarcoma. Improved local control, particularly in patients with high-grade tumors, was observed in the latter half of the study period despite the increased use of LSS. When the data were subjected to multivariate analysis, the following variables emerged as independent predictors of local failure: (1) age greater than 53 years, (2) presentation with local recurrence, (3) high grade, (4) less than adequate margins, (5) embryonal rhabdomyosarcoma, and (6) neurofibrosarcoma. The key to local control of sarcomas of the extremities is resection of the tumor with adequate margins. The role of adjuvant treatment, particularly following LSS, is still being evaluated. The risk factor profile should be considered when selecting a treatment program for patients with lower extremity sarcomas.
(Arch Surg 1986;121:1425-1433)
Author Affiliations
From the Departments of Surgery (Drs Collin, Shiu, and Brennan), Pathology (Dr Hadju), Biostatistics (Dr Godbold), and Radiation Oncology (Dr Hilaris), Memorial Sloan-Kettering Cancer Center, New York.
Footnotes
Accepted for publication Sept 9, 1986.
Presented in part at the 39th Annual Meeting of the Society of Surgical Oncology, Washington, DC, May 14, 1986.
Reprint requests to Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (Dr Brennan).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Vascular Reconstruction in the Resection of Soft Tissue Sarcomas
Ceraldi et al.
PERSPECT VASC SURG ENDOVASC THER 2000;12:67-83.
ABSTRACT
Long-term Outcome in 87 Patients With Low-Grade Soft-Tissue Sarcoma
Marcus et al.
Arch Surg 1993;128:1336-1343.
ABSTRACT
Prognostic Factors in Primary Retroperitoneal Soft-Tissue Sarcomas
Bevilacqua et al.
Arch Surg 1991;126:328-334.
ABSTRACT
Is Limb-Sparing Surgery Applicable to Neurogenic Sarcomas of the Extremities?
Bolton et al.
Arch Surg 1989;124:118-121.
ABSTRACT
Local Recurrence in Adult Soft-Tissue Sarcoma: A Randomized Trial of Brachytherapy
Brennan et al.
Arch Surg 1987;122:1289-1293.
ABSTRACT
|
